Lan G, Wang P, Chan RB, Liu Z, Yu Z, Liu X et al
3 A favorable committee vote reflects a judgment call about access and gray-market risk, not a verdict on efficacy
In short, neither topical nor oral glutathione is "better" for everyone
Description DSIP Structure CAS Number: 62568-57-4 Quantity: 15 mg per vial Molecular Formula: CHNO Molecular Weight: 848.8 g/mol Peptide Length: 9 amino acids Research Use Only For laboratory research use only
List of Secondary Sources 1.10
By 2024, the therapy had been approved in over 60 countries, and Vertex secured favorable pricing and access deals, including a key agreement with the UKs National Institute for Health and Care Excellence (NICE) that extended coverage to more patients